Neisseria meningilidis is one of several important bacterial pathogens that secrete a specific protease capable of cleaving human immunoglobulin Al (IgAl) (4, 5) . In gonococci, these autocatalytic sites separate the extracellular mature protease from a released a protein and an outer membrane-associated j3 protein required for extracellular secretion (4).
genotypes and representing major epidemics and carrier strains from 19 countries. Ofthe two IgA1 cleavage specificities previously observed, isolates associated with epidemics of meningococcal disease showed exclusively type 1 IgAl protease activity. Considerable heterogeneity oftheN. meningitidis IgAl protease was demonstrated at both the protein and gene levels. Thus, five different forms of IgAl protease were detected with enzyme-neutralizing antibodies raised in rabbits. An antiserum raised against a single type 2 IgAl protease inhibited the enzyme activity of all strains examined, a finding of potential significance for the possible application of IgAl protease in a vaccine against meningococcal disease. Examination of the iga gene region with restriction endonucleases revealed a high degree of polymorphism among strains belonging to some multilocus enzyme genotypes. The different iga gene types did not correlate with cleavage type or inhibition of the IgAl protease. Our findings indicate that horizontal genetic exchange occurs in vivo with considerably different frequency in different clones of meningococci.
The immunoglobulin Al (IgAl) proteases are highly specific bacterial enzymes that cleave certain peptide bonds in the hinge region ofhuman IgAl. They are excreted by pathogenic members of the genera Neisseria, Haemophilus, Streptococcus, Prevotella (Bacteroides), and Capnocytophaga and are considered important factors of virulence (1) (2) (3) . The only known alternative substrates of the Neisseria and Haemophilus IgAl proteases are autocatalytic sites inside the protease precursor molecule (4, 5) . In gonococci, these autocatalytic sites separate the extracellular mature protease from a released a protein and an outer membrane-associated j3 protein required for extracellular secretion (4) .
Homologies among the nucleotide sequences have been shown for the IgAl protease genes (iga) of Neisseria meningitidis, Neisseria gonorrhoeae, and Haemophilus influenzae (6) , suggesting a common evolutionary origin. Despite this overall similarity, a surprising degree of heterogeneity has been found, even among the IgAl proteases secreted by members of a single species. The enzymes differ in the exact position of cleavage in the human IgAl hinge region. Proteases cleaving one of several prolyl-seryl bonds are called type 1 IgAl proteases, and those attacking one of several prolylthreonyl bonds are designated as type 2 IgAl proteases (7) (8) (9) . Furthermore, among IgAl proteases released by H. influenzae strains, at least 15 different antigenic types have been detected by the use of enzyme-neutralizing antisera, and a correlation between these "inhibition types" and capsular serotype has been observed (8 (11, 12) . Additional strains were chosen from the authors' collections to increase the representation of three ETs responsible for epidemics in several countries.
The 133 isolates were assigned to 88 multilocus enzyme genotypes on the basis of electrophoretically detectable allelic variation in 15 metabolic enzymes. Ten of the 14 main lineages of N. meningitidis were represented in the strain collection examined, and isolates belonging to 35 of the 61 clusters described (11) were included. The isolates were serologically examined and assigned to serogroups and serotypes as described (11) .
IgAl Protease Activity. Each strain was examined for IgAl protease activity by overnight incubation in a solution of human IgAl paraprotein (1.5 mg/ml) purified from the plasma of a patient with myelomatosis (13) in Tris HCl, pH 7.4. IgAl cleavage was detected by immunoelectrophoresis and SDS/PAGE as described (13 (8) . Immunoglobulins were isolated from rabbit blood and redissolved in 0.05 M Tris-HCI, pH 7.4. IgAl proteases from 32 selected meningococcal strains and the two gonococcal strains were prepared, and the enzyme activity was adjusted so that it was twice the lowest concentration that would induce complete cleavage of 0.5 mg of IgAl per ml in 1 hr at 350C in a reaction mixture of 1 vol of enzyme preparation and 1 vol of substrate solution. The ability of the four antisera to inhibit IgAl cleaving activity in each of the 32 adjusted protease preparations was examined by determining the antiserum dilution that caused 50% inhibition of the protease. Fifty microliters each of protease preparation and respective 2-fold serum dilutions were mixed and incubated for 1 hr at room temperature. Fifty microliters of IgAl substrate (1.5 mg/ml in Tris-HCl, pH 7.4) was added, and cleavage was detected by immunoelectrophoresis after incubation of the reaction mixture for 18 hr (13) . The IgAl proteases of the remaining 98 meningococcal strains were examined by suspending a loop full of bacteria from a chocolate agar culture in 40 ,ul of undiluted antiserum.
After a 1-hr incubation at room temperature 40 p1L of substrate was added, and the activity was determined as described.
Preparation and Analysis of Chromosomal DNA. Bacteria were harvested from chocolate agar after 24 hr and were lysed with lysozyme, EDTA, and Triton X-100. Proteins were degraded by incubation with proteinase K (15), and DNA was purified from the suspension with Qiagen-tube 20, as described by the manufacturer (Diagen, Dusseldorf, F.R.G.). Restriction endonucleases were purchased from Boehringer Mannheim and used according to the manufacturer's instructions. The resulting DNA fragments were separated by 0.8% agarose gel electrophoresis and were subsequently blotted onto nylon membranes (Nytran-NY 13N, Schleicher & Schuell) (15) . The DNA probe for hybridization was isolated and labeled with [32P]dATP (Amersham) incorporated by nick-translation as described (15) . Hybridization was done under stringent conditions (posthybridization wash: 0.5x standard saline citrate/0.1% SDS at 60°C) (15) . As probe we used a fragment of the iga gene from N. gonorrhoeae strain F62 (Fig. 1) ; it was isolated as a 4.2-kilobase (kb) HindIII fragment from the recombinant Escherichia coli plasmid pVD105 (16) donated by J. M. Koomey (The Rockefeller University, New York).
RESULTS
IgAl Protease Activity and Enzyme Type. Of the 133 N. meningitidis strains analyzed, 130 had detectable IgAl protease activity. The three negative strains had all been isolated from patients with meningococcal disease, and two of these strains were assigned to the same electrophoretic type (ET71). Nine other strains of the same ET all showed IgAl protease activity.
The majority (70%) of the IgAl protease-producing strains showed protease activity of cleavage type 1. All 18 serogroup A strains possessed a type 1 protease, but no relationship was found between protease cleavage type and other serogroups (data not shown). All serotype 2a, 2b, and 21 and all serotype 15:P1.16 strains produced a type 1 protease, whereas all serotype 2c strains produced a type 2 protease.
Fifty-eight of the IgAl protease-producing strains belonged to clones that have caused epidemics (ET clusters A4, B2, El, E2, and Il) (11) . All these strains, except the strain (Table 1) .
The five inhibition types identified showed no correlation with serogroup or serotype of the strains. However, in most cases strains assigned to a single ET cluster produced IgAl protease of a single inhibition type. Exceptions were clusters encompassing both type 1 and type 2 protease-producing strains (Table 2 ). In addition, strains being exceptional within the cluster because of their iga gene RFLP pattern often produced an IgAl protease of exceptional inhibition type [e.g., the strain of cluster El, ET64 (Table 2) (Fig. 1) show that the iga gene is a single-copy gene.
The total number ofRFLP variants detected among the 133 strains after digestion by the three 6-base restriction enzymes added up to >20. Table 2 details the data for 81 strains assigned to seven ET clusters. For further evaluation of the extent of variation among the meningococcal iga genes, DNA from 24 strains from two epidemic clones that belonged to ET clusters E2 and I1 were digested with the 4-base restriction endonuclease Hae III. This procedure revealed an additional six iga gene types among 13 strains assigned to cluster I1, five of these types were detected among 11 strains of a single ET (ET71). In contrast, the 11 strains of ET-cluster E2 remained homogeneous ( (7). Not surprisingly, both cleavage types 1 and 2 IgAl proteases were seen among the meningococcal strains examined. However, interestingly all but 1 of 58 isolates from clones of meningococci associated with epidemics (ET clusters A4, B2, El, E2, and I1) produced a type 1 protease. IgAl protease of cleavage type 1 is also produced by all strains ofH. influenzae serotype b, the serotype responsible for virtually all cases of invasive disease from this organism, and by N. gonorrhoeae strains of the AHU auxotype, which is associated with disseminated gonococcal disease (8, 9) . Why most pathogenic clones of Haemophilus and Neisseria are associated with IgAl proteases of type 1 cleavage specificity is unclear. The dipeptide Thr-Pro that separates type 1 and type 2 cleavage sites in the hinge region probably does not determine the biological effect of the IgAl cleavage. An alternative explanation is that the two types of proteases differ in other as-yet-unrealized inherent properties, such as the ability to cleave other substrates involved in pathogenicity.
The serological analysis on the meningococcal IgAl proteases revealed variations in epitopes involved in antibodyinduced enzyme neutralization. The actual epitopes, with which these antibodies react, are yet unknown. Probably they involve the catalytic site and/or the substraterecognition site of the protease. With the antisera used only five inhibition types were detected among the 130 proteaseproducing strains. Only a partial correlation between inhibition type and cleavage type was found (Table 1) , in contrast to our previous findings for H. influenzae IgAl proteases (8) . Thus, only one of the antisera (VK3) exclusively inhibited type 1 proteases, whereas another antiserum (HF13) inhibited all meningococcal proteases, regardless ofcleavage type. If IgAl proteases prove to be an important virulence factor, the latter protease type would be an obvious candidate for vaccine use. The variation at the protein level was also detected by RFLP analyses of the iga gene region. Among the three 6-base restriction enzymes used to examine all 133 strains, Pst I cleaved the iga gene at three sites (Fig. 1 ), in agreement with published physical maps of gonococcal and meningococcal iga genes (10, 14, 17) . More than 20 distinct arrangements of Pst I recognition sites were detected in the iga gene region. The size variation of hybridizing Pst I fragments representing the 5' and 3' ends of the iga gene and flanking sequences (Fig. 1) suggests that the meningococcal iga gene is located in a highly variable part of the chromosome.
By comparison with these published maps, it can be deduced that the internal Pst I sites of the iga gene are all located in the helper domain (Fig. 1) . Halter et al. (14) recently differentiated gonococcal iga genes into two types, Hi and H2, on location of the autoproteolytic sites and by size of the a and f3 proteins (Fig. 1) immune-escape purpose, as appears true for several other virulence factors in gonococci and meningococci (22) . However, the surprisingly small number of IgAl protease inhibition types detected seems to limit the immune-escape value of these variations, particularly as most meningococcal IgAl proteases shared "inhibitory" epitopes (Table 1) .
This study provides information on the worldwide variation among meningococcal IgAl proteases and shows that clones known to cause epidemics produce almost exclusively the type 1 enzyme. The observations reveal strong evidence for frequent horizontal gene transfer involving the iga gene region in some parts of natural populations of meningococci.
